Analysts expect BioAge Labs, Inc. to report revenue of 1.47 M for Q3 26, against a range of 1.34 M to 1.59 M. The most recent reported quarter, Q2 26, came in at 2.45 M, a 52.8% beat against the 1.60 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 1.45 M | 2.41 M | 2.05 M | 3.08 M | 2.77 M | 2.45 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 414,946.25 | 451,942.06 | 825,721.84 | 1.39 M | 1.14 M | 1.73 M | 1.59 M | 1.44 M | 183,994.73 | 193,453.22 | 1.77 M | 2.38 M | 990,831.19 | -238,424.91 | ||||||||||
| Low Estimate | 0.00 | 0.00 | 389,555.37 | 397,965.30 | 694,111.84 | 1.29 M | 948,276.26 | 1.48 M | 1.34 M | 1.25 M | 158,275.51 | 171,106.78 | 1.51 M | 2.19 M | 895,424.39 | -271,498.55 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 402,250.81 | 424,953.68 | 759,916.84 | 1.34 M | 1.04 M | 1.60 M | 1.47 M | 1.35 M | 171,135.12 | 182,280.00 | 1.64 M | 2.28 M | 943,127.79 | -254,961.73 |
Analysts expect BioAge Labs, Inc. to report earnings per share of -0.64 for Q3 26, against a range of -0.67 to -0.61. The most recent reported quarter, Q2 26, came in at -0.58, a 1.7% beat against the -0.59 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -6.70 | -1.00 | -0.36 | -0.60 | -0.56 | -0.72 | -0.52 | -0.58 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.70 | -0.74 | -0.47 | -0.48 | -0.51 | -0.71 | -0.63 | -0.56 | -0.61 | -0.58 | -0.48 | -0.51 | 0.06 | 0.47 | -0.96 | -1.30 | ||||||||||
| Low Estimate | -0.74 | -0.80 | -0.55 | -0.52 | -0.61 | -0.81 | -0.73 | -0.62 | -0.67 | -0.66 | -0.58 | -0.63 | 0.06 | 0.41 | -1.06 | -1.40 | ||||||||||
| Consensus Estimate | -0.72 | -0.77 | -0.51 | -0.50 | -0.56 | -0.76 | -0.68 | -0.59 | -0.64 | -0.62 | -0.53 | -0.57 | 0.06 | 0.44 | -1.01 | -1.35 |
Pull Wall Street consensus for BioAge Labs, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=BIOA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "BIOA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=BIOA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();